This project will assess the anti-bone resorption activity of AP-002 in vivo in a rat osteoporosis model.
Altum Pharmaceuticals Inc.
4 enregistrements totalisant 520,527.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $520,527 | 4 enregistrements |
Enregistrements
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.